logo

REGN

RegeneronยทNASDAQ
--
--(--)
--
--(--)

REGN Profile

Regeneron Pharmaceuticals, Inc.

A company that developing drugs to treat eye diseases, inflammatory diseases and cancer

Biological Technology
--
04/05/1991
NASDAQ Stock Exchange
15,410
12-31
Common stock
777 Old Saw Mill River Road, Tarrytown, New York 10591-6707
Production and sales of pharmaceutical products
Regeneron Pharmaceuticals, Inc. was incorporated in New York State in 1988. The company is a fully integrated biotechnology company that invents, develops, manufactures and commercializes medicines for people with serious diseases. Its core business strategy is built on a strong foundation of scientific research and proprietary technology, advancing a diverse portfolio of products and product candidates across multiple therapeutic areas.